A detailed history of Greenleaf Trust transactions in Eli Lilly & CO stock. As of the latest transaction made, Greenleaf Trust holds 26,064 shares of LLY stock, worth $23.6 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
26,064
Previous 29,034 10.23%
Holding current value
$23.6 Million
Previous $16.9 Million 19.81%
% of portfolio
0.19%
Previous 0.18%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

SELL
$592.2 - $792.28 $1.76 Million - $2.35 Million
-2,970 Reduced 10.23%
26,064 $20.3 Million
Q4 2023

Jan 31, 2024

BUY
$525.19 - $619.13 $2.74 Million - $3.23 Million
5,210 Added 21.87%
29,034 $16.9 Million
Q3 2023

Nov 09, 2023

BUY
$434.7 - $599.3 $37,384 - $51,539
86 Added 0.36%
23,824 $12.8 Million
Q2 2023

Aug 09, 2023

SELL
$350.74 - $468.98 $400,895 - $536,044
-1,143 Reduced 4.59%
23,738 $11.1 Million
Q1 2023

May 11, 2023

BUY
$310.63 - $364.82 $25,471 - $29,915
82 Added 0.33%
24,881 $8.54 Million
Q4 2022

Jan 25, 2023

SELL
$321.55 - $374.67 $13.9 Million - $16.2 Million
-43,274 Reduced 63.57%
24,799 $9.07 Million
Q3 2022

Nov 10, 2022

BUY
$296.48 - $337.87 $13.4 Million - $15.3 Million
45,191 Added 197.5%
68,073 $22 Million
Q2 2022

Aug 12, 2022

BUY
$278.73 - $327.27 $369,595 - $433,960
1,326 Added 6.15%
22,882 $7.42 Million
Q1 2022

Apr 27, 2022

BUY
$234.69 - $291.66 $226,710 - $281,743
966 Added 4.69%
21,556 $6.17 Million
Q4 2021

Feb 11, 2022

BUY
$224.85 - $279.04 $299,500 - $371,681
1,332 Added 6.92%
20,590 $5.69 Million
Q3 2021

Nov 12, 2021

BUY
$221.6 - $272.71 $51,189 - $62,996
231 Added 1.21%
19,258 $4.45 Million
Q2 2021

Aug 10, 2021

BUY
$180.55 - $233.54 $46,401 - $60,019
257 Added 1.37%
19,027 $4.37 Million
Q1 2021

Apr 30, 2021

BUY
$164.32 - $212.72 $316,316 - $409,486
1,925 Added 11.43%
18,770 $3.51 Million
Q4 2020

Feb 08, 2021

BUY
$130.46 - $172.63 $186,949 - $247,378
1,433 Added 9.3%
16,845 $2.84 Million
Q3 2020

Oct 30, 2020

SELL
$146.22 - $169.13 $135,692 - $156,952
-928 Reduced 5.68%
15,412 $2.28 Million
Q2 2020

Aug 12, 2020

BUY
$136.42 - $164.18 $327,271 - $393,867
2,399 Added 17.21%
16,340 $2.68 Million
Q1 2020

Apr 29, 2020

BUY
$119.05 - $147.35 $224,171 - $277,460
1,883 Added 15.62%
13,941 $1.93 Million
Q4 2019

Feb 11, 2020

BUY
$106.92 - $132.43 $36,673 - $45,423
343 Added 2.93%
12,058 $1.59 Million
Q3 2019

Nov 08, 2019

SELL
$106.79 - $116.16 $2,135 - $2,323
-20 Reduced 0.17%
11,715 $1.31 Million
Q2 2019

Jul 24, 2019

SELL
$110.79 - $129.32 $23,819 - $27,803
-215 Reduced 1.8%
11,735 $1.3 Million
Q1 2019

May 08, 2019

BUY
$111.31 - $131.02 $60,997 - $71,798
548 Added 4.81%
11,950 $1.55 Million
Q4 2018

Feb 07, 2019

BUY
$105.9 - $118.64 $51,149 - $57,303
483 Added 4.42%
11,402 $1.32 Million
Q3 2018

Oct 29, 2018

BUY
$85.86 - $107.31 $94,789 - $118,470
1,104 Added 11.25%
10,919 $1.17 Million
Q2 2018

Aug 07, 2018

BUY
$75.7 - $86.88 $203,330 - $233,359
2,686 Added 37.68%
9,815 $838,000
Q1 2018

Apr 30, 2018

SELL
$74.21 - $87.6 $8,830 - $10,424
-119 Reduced 1.64%
7,129 $552,000
Q4 2017

Feb 08, 2018

BUY
$81.94 - $87.89 $90,297 - $96,854
1,102 Added 17.93%
7,248 $612,000
Q3 2017

Nov 13, 2017

BUY
$77.07 - $85.54 $473,672 - $525,728
6,146
6,146 $526,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $860B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Greenleaf Trust Portfolio

Follow Greenleaf Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenleaf Trust, based on Form 13F filings with the SEC.

News

Stay updated on Greenleaf Trust with notifications on news.